# US 2025/0378908 A1 · Identifying somatic pseudogenes as a proxy for restrotransposition activity detection

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0378908 A1
- Document ID: US20250378908A1
- Status: Published application
- Kind: A1
- Application number: 18/737,816
- Filed: 2024-06-07
- Published: 2025-12-11
- Earliest claimed: 2023-06-08
- Assignees: Guardant Health, Inc.
- Applicants: Guardant Health, Inc.
- Inventors: Vitaly BALAN; Aaron Isaac HARDIN; James HART; Sofia MEDINA RUIZ
- Web page: https://patentgrep.com/patent/US20250378908A1

## CPC

- G16B 20/20: Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
- G16B 30/10: Sequence alignment; Homology search
- G16B 45/00: ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks
- G16H 40/67: for remote operation
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

Described herein is a method for detecting pseudogenes, including processed pseudogenes, further including detection for measuring retrotrasposon element activity. Such measurements are useful in screening and detecting cancer in subjects, including predicting the likelihood or cancer, recurrence, treatment responsiveness and selection.

## Claims

### Claim 1

A method comprising:
determining a plurality of sequence reads of a target region of a chromosome of a subject, wherein the target region of the chromosome comprises one or more loci;
aligning the plurality of sequence reads to a reference genome;
subtracting aligned pairs from the plurality of sequence reads to generate a plurality of candidate sequence reads;
aligning the plurality of candidates sequences reads to a plurality of known allele sequences;
determining, based on the alignment, for each known allele sequence of the plurality of known allele sequences, a number of sequence reads that aligned to each known allele sequence;
extracting unaligned candidate sequence reads;
mapping unaligned candidate sequence reads to the reference genome; and
determining, based on the unaligned candidate sequence reads that mapped to the reference genome, one or more integration sites present at the one or more loci.

### Claim 2 (depends on 1)

The method of claim 1, wherein the plurality of known allele sequences comprise a plurality of known reference repeats.

### Claim 3 (depends on 1)

The method of claim 1, wherein only one read of a read pair is aligned to a repeat.

### Claim 4 (depends on 1)

The method of method of claim 1, comprising determining retrotransposition activity based on the one or more integration sites present at the one or more loci.

### Claim 5 (depends on 1)

The method of claim 1, further comprising:
obtaining a sample from the subject; and
sequencing the sample to obtain the plurality of sequence reads of the target region of the chromosome.

### Claim 6 (depends on 1)

The method of claim 1, further comprising:
determining, based on the mapping, for each read of the plurality of sequence reads, one or more integration sites present at the one or more loci.

### Claim 7 (depends on 1)

The method of claim 1, wherein the target region comprises one or more of the following genes: ARHGAP27P1, FLT1P1-AS, FOXO3P, Pseudogenes of FTH1, GUSBP11, MT1JP, PEBP1P2, SNRPFP1, SNX17 and TUSC2P.

### Claim 8 (depends on 1)

The method of claim 1, wherein the target region comprises one or more of the following genes: ADAM5, ACTG1P25, AK4P1, BRAFP1, BRCA1P1, CYP2A7, CYP4Z2P, DUXAP8, EBLN3P, FTH1P3, FLT1P1-S, OGFRP1, LGMNP1, MSTO2P, MYLKP1, OCT4-pg4, PCNAP1, PDIA3P1, PPM1K, PRELID1P6, PTENP1-AS, PTTG3P, RPSAP52, SALL4P5, TCAM1P, TDGF1P3, RP9P, UBE2CP3.

### Claim 9 (depends on 1)

The method of claim 1, wherein determining one or more integration sites comprises identifying one or more exon-exon junctions in the reference genome.

### Claim 10 (depends on 9)

The method of claim 9, wherein the one or more exon-exon junctions is not of germline origin.

### Claim 11 (depends on 9)

The method of claim 9, wherein determining one or more integration sites comprises mapping to a maximum pseudogene sequence comprising all exons.

### Claim 12 (depends on 11)

The method of claim 11, wherein mapping comprises determining unaligned candidate sequence spanning one or more exon-exon junctions.

### Claim 13 (depends on 12)

The method of claim 12, wherein two reads of a read pair is mapped to different exons.

### Claim 14 (depends on 1)

The method of claim 1, wherein determining, based on the numbers of sequence reads that aligned to each known allele sequence, for the one or more loci, the known allele sequences present at the one or more loci comprises determining one or more known allele sequences having a highest number of sequence reads aligned.

### Claim 15 (depends on 1)

The method of claim 1, wherein the reads that aligned to each known allele sequence are grouped into read families, and the method further comprises, determining a number of sequence read families that are aligned to each known allele sequence.

### Claim 16 (depends on 12)

The method of claim 12, wherein determining, for the one or more loci, the known allele sequences present at the one or more loci based on the numbers of sequence read families that aligned to each known allele sequence.

### Claim 17 (depends on 1)

The method of claim 1, further comprising determining a length of a portion of each known allele sequence aligned to two or more sequence reads of the plurality of sequence reads.

### Claim 18 (depends on 1)

The method of claim 1, further comprising:
sorting, for a locus, the known allele sequences present at the locus by the number of sequence reads that aligned to each known allele sequence;
determining, for the locus, a first known allele sequence with a highest number of sequence reads aligned;
inserting the first known allele sequence with the highest number of sequence reads aligned into a superset;
determining one or more known allele sequences that aligned to reads that are a subset of the reads aligned to the first known allele sequence; and
inserting the one or more known allele sequences into the superset.

### Claim 19 (depends on 15)

The method of claim 15, wherein the superset comprises a graph data structure.

### Claim 20 (depends on 16)

The method of claim 16, wherein the graph data structure comprises a directed acyclic graph.

### Claim 21 (depends on 16)

The method of claim 16, wherein the graph data structure represents a Hasse diagram.

### Claim 22 (depends on 15)

The method of claim 15, further comprising:
determining that the locus is associated with a single superset; and
determining the first known allele sequence of the single superset as the allele present at the locus.

### Claim 23 (depends on 15)

The method of claim 15, further comprising determining a plurality of supersets for the locus.

### Claim 24 (depends on 20)

The method of claim 20, further comprising
determining, based on the plurality of supersets for the locus, two supersets with a cumulative largest number of distinct reads; and
determining the first known allele sequence of each of the two supersets as the alleles present at the locus.

### Claim 25 (depends on 1)

The method of claim 1, further comprising, assisting in a communication of the known allele sequences present at the one or more loci to a medical provider.
